Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs. Shares of JNJ fell nearly 1% to $153.21 apiece in afternoon trading today. On the company’s first-quarter earnings call, CFO Joseph Wolk explained the impact that new Trump Administration tariffs could have on the company after first […]
Johnson & Johnson
Johnson & Johnson MedTech completes first cases with Ottava surgical robot
Johnson & Johnson MedTech announced today that investigators completed the first cases with its Ottava surgical robot. The cases, performed by Dr. Erik Wilson, mark the first clinical experience with the highly anticipated robotic platform. Wilson, chief of minimally invasive surgery and elective general surgery at UT Health Houston, performed Roux-en-Y gastric bypass surgery using […]
Medtech stocks sink in trade war
The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the Trump administration’s new global trade war. The S&P 500 briefly entered bear market territory today as it swung wildly in response to chaotic news reports about what the administration and other countries […]
J&J’s Shockwave enrolls first patient in novel forward IVL study
Johnson & Johnson MedTech‘s Shockwave Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter. FORWARD CAD, an FDA investigational device exemption (IDE) study, evaluates the safety and efficacy of the company’s latest intravascular lithotripsy (IVL) catheter. It aims to treat calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting. […]
Johnson & Johnson has positive dual-energy ablation data
Johnson & Johnson MedTech announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch SF catheter. The medtech giant said investigators presented findings at the annual meeting of the European Heart Rhythm Association (EHRA) in Vienna, Austria. Outcomes showed that the dual-energy catheter proved 86.9% effective when treating patients with high adherence to […]
Johnson & Johnson MedTech launches electrosurgical generator that will work with Ottava surgical robot
Johnson & Johnson MedTech announced today that it launched its FDA-cleared Dualto energy system. Dualto is a surgical solution that combines multiple energy modalities into an integrated platform for use across open and minimally invasive surgery. J&J designed it to work with its Polyphonic Fleet software application for device management. Additionally, the company plans for […]
Federal court revives Getinge heart pump patent suit against J&J’s Abiomed
The U.S. Court of Appeals for the Federal Circuit has brought back a patent infringement case between Getinge’s Maquet and Johnson & Johnson’s Abiomed. This lawsuit dates back to 2016, when heart pump maker Abiomed, now a Johnson & Johnson MedTech unit, sued Getinge’s Maquet for a judgment of non-infringement of a trio of patents. Counter-suits later […]
J&J to invest $55B in U.S. operations
Johnson & Johnson announced it will invest more than $55 billion in its U.S. pharma and medtech operations over the next four years. The investment is a 25% increase over its previous investment cycle. It bolsters the New Brunswick, N.J.-based company’s manufacturing, R&D and technology infrastructure. Johnson & Johnson said the investment is expected to […]
Johnson & Johnson Neurovascular has a new worldwide president
Johnson & Johnson MedTech Neurovascular has a new leader. Following former J&J MedTech Neurovascular Worldwide President Mark Dickinson’s announcement last week that he was leaving Johnson & Johnson after a 26-year career with the world’s second-largest device company, Christian Cuzick announced his promotion to the role. “I look forward to working with our incredible team […]
Johnson & Johnson Neurovascular leader heads for the exit
Johnson & Johnson MedTech Neurovascular Worldwide President Mark Dickinson is leaving J&J after a 26-year career at the world’s second-largest device company. (UPDATE: His replacement is Christian Cuzick, Cuzick announced after Dickinson said he was stepping down.) J&J MedTech has reportedly been exploring a sale of its neurovascular business, which was previously known as Cerenovus. […]
Johnson & Johnson MedTech showcases new orthopedic offerings at AAOS
Johnson & Johnson MedTech announced new regulatory nods for multiple orthopedic technology offerings. The company said its VOLT system received CE mark and its Inhance Intact system won FDA 510(k) clearance. It showcased these technologies, alongside several others, at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego. VOLT, a variable […]
